Delivery Order SPE2DB22D1002-SPE2DB25FLAP1
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,163.76, is a Firm Fixed Price Delivery Order for the supply of Ketorolac 30 mg/ml vials. The contract has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,357.72, is a firm fixed-price delivery order for the supply of Ketorolac 30 mg/mL vials. The contract has a period of performance through June 13, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.76 firm fixed-price delivery order contract is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of Ketorolac 30 mg/ml vials. The award has a fixed-price delivery order contract type with a ceiling value of $2,287.60 and an ultimate completion date of May 31, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 30 mg/mL vials. The contract has a ceiling value of $1,028.16 and an ultimate completion date of November 22, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Ketorolac 30 mg/ml vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award has a total ceiling value of $15,231.87 and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 11, 2024. The contract is not set aside for a specific business type. As one of the largest pharmaceutical distributors in the U.S.,...
This federal contract award, valued at $1,939.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract to supply 4568105691 KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has a firm fixed-price pricing type and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order valued at $2,909.40 with a firm fixed price and an ultimate completion date of June 11, 2025. The contract is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,124.88. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,451.88 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/ml vials, a pharmaceutical product. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up...